Cue Biopharma is an innovative immunotherapy company dedicated to developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. Cue Biopharma’s Immuno-STAT Biologics are designed to engage directly with and modulate the activity of disease-associated T cells in the patient’s body, potentially offering significant therapeutic advantages while minimizing or eliminating unwanted side effects.

Biotechnology

Cue Biopharma

Cue Biopharma's headquarters in Cambridge, MA, United States

Dan Passeri

Siddhartha Shrivastava

Steven Quayle

Matteo Levisetti

Kerri-Ann Millar

Colin Sandercock

Hidde Ploegh

Pamela D. Garzone

Karolina Palucka

Aaron Fletcher

Peter Kiener

Abul K. Abbas

Michael Kalos

Fred Driscoll

Ronald D. Seidel III

Steven Almo

Patrick Verheyen

Rafi Ahmed

Frank Morich

The Research and Development Team at Cue Biopharma is focused on advancing the company's immunotherapy therapies by conducting cutting-edge research on biologics designed to modulate the immune system. This team, composed of scientists and leaders across pharmacology, translational medicine, and toxicology, collaborates to design, test, and refine novel therapies that target disease-associated T cells, ultimately aiming to bring innovative treatment solutions for cancers and autoimmune disorders from the lab to clinical application.

Research and Development Team

The Advisory Team at Cue Biopharma provides strategic guidance and expert insights to enhance the company’s innovative immunotherapy development efforts. Comprising seasoned advisors with extensive experience in biopharmaceuticals and immunology, the team collaborates on scientific and clinical strategies, ensuring the alignment of research initiatives with industry best practices and regulatory requirements. Their collective expertise helps to optimize the efficacy of Cue Biopharma's Immuno-STAT Biologics while navigating the complexities of drug development and commercialization.

Advisory Team

The Legal and Regulatory Affairs team at Cue Biopharma is responsible for ensuring compliance with applicable laws and regulations governing the development and commercialization of innovative immunotherapies. This team navigates intricate regulatory landscapes, manages legal contracts, and supports clinical operations by providing guidance on regulatory submissions and intellectual property matters, thereby facilitating the advancement of Cue Biopharma's pioneering biologics safely and effectively.

Legal and Regulatory Affairs

This department focuses on the oversight and management of chemistry, manufacturing, and controls activities within the organization.

CMC Operations

This department focuses on advancing scientific knowledge and developing innovative solutions through rigorous research and experimentation.

Research and Development

This department focuses on advancing scientific knowledge and developing new medical therapies through research and translational medicine.

Cue Biopharma

Org chart

Board & advisors

Teams

Research and Development Team

Advisory Team

Legal and Regulatory Affairs

CMC Operations

Research and Development

Research and Innovation

Offices

Cue Biopharma

Org chart

Board & advisors

Teams

Research and Development Team

Advisory Team

Legal and Regulatory Affairs

CMC Operations

Research and Development

Research and Innovation

Offices

Related companies